About Rezolute (RZLT)
Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of conge... Read more
- USD5.95
- USD6.30
- USD5.95
- USD6.65
- 12.90%
- --
- 402.15k
- 1.31M
- 504M
- 2.22
- 36.60%
Stock News
2 hours ago
An analyst just upgraded a cybersecurity stock that we've been pounding the table on
CNBC
2 hours ago
Sydney Sweeney and Trump may have been good for American Eagle’s stock, but maybe not demand, data shows
MarketWatch
4 hours ago
Form 8.3 - American Axle & Manufacturing Holdings, Inc.
Yahoo
5 hours ago
Anthropic is giving Claude to the U.S. government for $1 as AI companies try to win key agencies
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
